Alejandro A Gru, MD

Dermatopathology
Pathology - Anatomic, Pathology - Hematology
More specialties
Profile Headshot

Overview

Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. 

Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.

Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. 

Areas of Expertise / Conditions Treated

  • Adnexal Tumors
  • Cutaneous Lymphoma
  • Histiocytosis
  • Inflammatory Skin Diseases
  • Melanoma

Academic Appointments

  • Leonard C. Harber Professor of Dermatology at CUMC

Administrative Titles

  • Director of Dermatopathology, NewYork-Presbyterian Hospital/Columbia University Iriving Medical Center
  • Director of ACGME-accredited Dermatopathology fellowship

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

Credentials & Experience

Education & Training

  • MD, 2003 University of Buenos Aires, Argentina
  • Internship: 2008 Washington University School of Medicine
  • Residency: 2011 Washington University School of Medicine
  • Fellowship: 2013 Washington University School of Medicine

Committees, Societies, Councils

  • Current President of the United States Cutaneous Lymphoma Consortium (USCLC)
  • The American Society of Dermatopathology committees
  • The United States and Canadian Academy of Pathology

Editorial Boards

  • The Journal of the American Academy of Dermatology
  • The American Journal of Surgical Pathology
  • Modern Pathology
  • Histopathology

Board Certifications

  • Dermatopathology
  • Anatomic Pathology
  • Hematopathology

Research

Dr. Gru’s clinical and translational research has focused on cutaneous lymphomas, viral-associated lymphoproliferative disorders, other cutaneous hematopoietic disorders, histiocytoses, mastocytosis, melanocytic tumors, and adnexal neoplasms of the skin. Dr. Gru has authored more than 250 peer-reviewed articles and is the Senior Editor of the 1st and 2nd editions of the books Hematopathology of the Skin and Pediatric Dermatopathology & Clinical Dermatology. He has also authored several chapters for the Haematolymphoid and Skin Tumour books of the World Health Organization (WHO) Classification of Tumours, the most prestigious of the pathology classifications. 
Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others.